Reports for NXSTAGE MEDICAL INC
Company Name NXSTAGE MEDICAL INC |
||
|---|---|---|
Totals |
||
Shortage reports |
4 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 1 (25%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 3 (75%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
0 (0%) |
|
Overdue reports |
1 (100%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 303) | 176.5G 23.1G 2.13G 4.63G 1.57G 116.6G | SOLUTION | Resolved | 2018-12-03 | 2019-06-11 | 68413 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305) | 176.5G 23.1G 2.13G 4.63G 1.57G 116.6G | SOLUTION | Resolved | 2018-12-03 | 2019-06-11 | 68419 |
| NXSTAGE PUREFLOW SOLUTION RFP-207-CAN | 5.552G 0.102G 1.1G 0.075G 0.221G 8.408G | SOLUTION | Anticipated shortage | 2025-03-04 | 2025-04-30 | 251900 |
| NXSTAGE PUREFLOW SOLUTION RFP-209-CAN | 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G | SOLUTION | Resolved | 2019-02-15 | 2019-03-12 | 76025 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0